|
|
Vaccine Detail
|
Unconjugated Lymphoma Ig Id Vaccine |
| Vaccine Information |
- Vaccine Name: Unconjugated Lymphoma Ig Id Vaccine
- Target Pathogen: Cancer
- Target Disease: Cancer
- Vaccine Ontology ID: VO_0007091
- Type: Peptide vaccine
- Status: Clinical trial
- Host Species for Licensed Use: Human
- Host Species as Laboratory Animal Model: Human
- Description: This is for Lymphoma Cancer (Karyampudi and Ghosh, 2008). A vaccine consisting of lymphoma-specific immunoglobulin that is not conjugated to a carrier molecule. Vaccination with unconjugated lymphoma Ig Id may stimulate the host immune system to mount a cytotoxic T lymphocyte (CTL) response against lymphoma cells, resulting in decreased tumor growth (NCI04) (NCIT_C2821).
|
| Host Response |
|
|
| References |
Karyampudi and Ghosh, 2008: Karyampudi L, Ghosh SK. Mycobacterial HSP70 as an adjuvant in the design of an idiotype vaccine against a murine lymphoma. Cellular immunology. 2008; 254(1); 74-80. [PubMed: 18715553].
NCIT_C2821: [https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C2821]
|
|
